Soleno Therapeutics (SLNO) Net Cash Flow: 2013-2019
Historic Net Cash Flow for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2019 value amounting to -$5.0 million.
- Soleno Therapeutics' Net Cash Flow fell 140.13% to -$5.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$16.8 million, marking a year-over-year decrease of 382.43%. This contributed to the annual value of -$81.8 million for FY2024, which is 152.72% down from last year.
- Latest data reveals that Soleno Therapeutics reported Net Cash Flow of -$5.0 million as of Q4 2019, which was down 16.25% from -$4.3 million recorded in Q3 2019.
- Soleno Therapeutics' Net Cash Flow's 5-year high stood at $12.4 million during Q4 2018, with a 5-year trough of -$5.0 million in Q4 2019.
- Moreover, its 3-year median value for Net Cash Flow was -$2.4 million (2017), whereas its average is $231,333.
- As far as peak fluctuations go, Soleno Therapeutics' Net Cash Flow crashed by 446.99% in 2016, and later spiked by 683.65% in 2017.
- Soleno Therapeutics' Net Cash Flow (Quarterly) stood at $774,813 in 2015, then slumped by 446.99% to -$2.7 million in 2016, then surged by 526.00% to $11.5 million in 2017, then climbed by 8.20% to $12.4 million in 2018, then crashed by 140.13% to -$5.0 million in 2019.
- Its Net Cash Flow was -$5.0 million in Q4 2019, compared to -$4.3 million in Q3 2019 and -$3.9 million in Q2 2019.